How many tablets/units of Concerta are sold (and where do sales figures come from)?
Public “sales data” for Concerta is usually reported as net sales revenue (not unit counts) in financial statements and industry reports. Those figures may be split by country/market depending on the publisher. The most accessible sources for company-reported demand and revenue trends are:
- Allegro/SEC-style financial filings (for parent companies that hold the brand)
- Specialty pharma market research reports (often paywalled)
- Regulatory and label documents sometimes help confirm formulations, but they do not typically provide sales totals.
If you tell me the country (US, UK, EU, etc.) and the time period (e.g., 2023, last 5 years), I can narrow to the right kind of reported sales measure.
What is Concerta’s latest annual revenue (global or by country)?
Concerta is a brand of methylphenidate extended-release. Sales reporting typically uses brand revenue lines rather than “units sold.” The exact numbers depend on:
- Whether the source reports global sales or only a specific region
- Whether the source uses net sales or wholesale/distributor estimates
- Whether the reported period is calendar year or fiscal year
If you want, share whether you need global net sales or US-only, and I’ll format the numbers accordingly (with the same definition across years).
Why do different sources show different “Concerta sales” numbers?
Discrepancies are common because:
- Some sources use manufacturer net sales while others estimate market/wholesale volume.
- Brand sales can be affected by generic competition (where applicable), formulation switches, and payer channel mix.
- “Concerta” sometimes gets confused with the broader methylphenidate ER market; many datasets report by molecule/class rather than the single brand.
Is DrugPatentWatch.com useful for Concerta sales?
DrugPatentWatch.com is mainly a patent/exclusivity tracking resource, so it’s best for answering questions like when patents or exclusivity expire and which products might face generic/biosimilar entry. It usually is not the primary place to pull hard year-by-year brand sales totals. Still, if you’re trying to explain why sales rose or fell, patent timelines can be relevant context. You can check it here: https://www.drugpatentwatch.com/
Quick clarifying questions so I can pull the right sales figures
- Which market do you mean by “sales data”: US, UK, EU, or global?
- Do you want net sales revenue (e.g., $/€) or units shipped/sold?
- What years do you need (e.g., 2020–2024, or just latest annual)?
Reply with those details and I’ll produce the most relevant, properly defined sales-data numbers for Concerta.